Connor Clark & Lunn Investment Management Ltd. Buys Shares of 59,970 Lifevantage Corporation $LFVN

Connor Clark & Lunn Investment Management Ltd. purchased a new position in Lifevantage Corporation (NASDAQ:LFVN) in the second quarter, Holdings Channel.com reports. The firm purchased 59,970 shares of the company’s stock, valued at approximately $784,000.

Several other hedge funds have also recently made changes to their positions in LFVN. Los Angeles Capital Management LLC purchased a new stake in Lifevantage in the second quarter worth approximately $288,000. AlphaQuest LLC lifted its holdings in shares of Lifevantage by 12,659.7% during the 2nd quarter. AlphaQuest LLC now owns 7,911 shares of the company’s stock valued at $103,000 after buying an additional 7,849 shares during the period. Capital Management Corp VA boosted its stake in shares of Lifevantage by 77.0% in the 2nd quarter. Capital Management Corp VA now owns 1,266,110 shares of the company’s stock worth $16,561,000 after buying an additional 550,607 shares during the last quarter. Farther Finance Advisors LLC bought a new stake in shares of Lifevantage in the second quarter worth $25,000. Finally, Goldman Sachs Group Inc. increased its position in Lifevantage by 24.5% during the first quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company’s stock valued at $649,000 after acquiring an additional 8,762 shares during the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Lifevantage

In other Lifevantage news, Director Michael A. Beindorff sold 35,000 shares of the stock in a transaction on Friday, November 7th. The stock was sold at an average price of $6.92, for a total value of $242,200.00. Following the completion of the sale, the director owned 56,413 shares in the company, valued at approximately $390,377.96. This represents a 38.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last ninety days, insiders sold 40,325 shares of company stock valued at $298,990. Corporate insiders own 21.95% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on LFVN. Wall Street Zen cut Lifevantage from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Lifevantage in a report on Monday. Finally, Lake Street Capital reaffirmed a “buy” rating and set a $12.00 target price on shares of Lifevantage in a report on Wednesday, November 5th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $23.50.

Lifevantage Trading Up 3.0%

Shares of NASDAQ:LFVN opened at $6.48 on Wednesday. The stock has a 50 day moving average of $8.91 and a 200 day moving average of $11.47. The company has a market cap of $82.30 million, a PE ratio of 8.76 and a beta of 0.22. Lifevantage Corporation has a 12-month low of $5.98 and a 12-month high of $27.38.

Lifevantage (NASDAQ:LFVN) last released its earnings results on Tuesday, November 4th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The company had revenue of $47.56 million for the quarter, compared to analysts’ expectations of $54.74 million. Lifevantage had a net margin of 4.29% and a return on equity of 33.75%. Lifevantage has set its FY 2026 guidance at 1.000-1.150 EPS.

Lifevantage Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Monday, December 1st will be issued a $0.045 dividend. The ex-dividend date of this dividend is Monday, December 1st. This represents a $0.18 annualized dividend and a yield of 2.8%. Lifevantage’s dividend payout ratio is currently 23.38%.

Lifevantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.